Product Program year 2025 Source: CMS Open Payments

Coroflow

Device Vascular

PDI 07350111070014

Open in the dashboard

General payments

$954,343

4,454 payments

Research payments

$553,538

3 payments

Through program year 2025, $954,343 in general payments and $553,538 in research payments were reported against Coroflow (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $272,686 1,348
2024 General $318,798 1,688
2024 Research $13,538 1
2023 General $347,479 1,199
2022 General $15,380 219
2022 Research $540,000 2

Breakdown

Who paid General payments · program years 2022–2025
  1. Abbott Laboratories $954,343 4,454 payments
Top recipients General payments · program year 2025
  1. Hayder Hashim Cardiovascular Disease · Washington, DC $47,479 17% · 67 payments
  2. Bruce Samuels Cardiovascular Disease · Beverly Hills, CA $25,068 9% · 53 payments
  3. Jennifer Tremmel Interventional Cardiology · Stanford, CA $23,709 9% · 4 payments
  4. Salvatore Mannino Interventional Cardiology · Marietta, GA $17,090 6% · 18 payments
  5. Nadia Sutton Interventional Cardiology · Nashville, TN $16,050 6% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $133,360 50% · 244 practitioners
  2. Cardiovascular Disease Internal Medicine $103,024 38% · 144 practitioners
  3. Internal Medicine $10,433 4% · 50 practitioners
  4. Vascular Surgery Surgery $4,931 2% · 5 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $2,190 <1% · 32 practitioners

The top 5 of 50 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $67,531 25% · 51 recipients
  2. District of Columbia $47,635 17% · 4 recipients
  3. Tennessee $22,040 8% · 17 recipients
  4. Georgia $18,877 7% · 22 recipients
  5. Texas $13,979 5% · 71 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

4,454 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record